Immunogenicity of a yeast-derived hepatitis B vaccine in hemodialysis patients
- 4 September 1989
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 87 (3) , S30-S32
- https://doi.org/10.1016/0002-9343(89)90528-7
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Hepatitis B Vaccine in Patients Receiving HemodialysisNew England Journal of Medicine, 1984
- EFFICACY OF HEAT-INACTIVATED HEPATITIS B VACCINE IN HAEMODIALYSIS PATIENTS AND STAFFThe Lancet, 1983
- Immunogenicity of a hepatitis B subunit vaccine in hemodialysis and in renal transplant recipientsAntiviral Research, 1983
- RANDOMISED PLACEBO-CONTROLLED TRIAL OF HEPATITIS B SURFACE ANTIGEN VACCINE IN FRENCH HAEMODIALYSIS UNITS: II, HAEMODIALYSIS PATIENTSThe Lancet, 1981
- PREVALENCE OF HEPATITIS B “e” ANTIGEN AND ITS ANTIBODY IN VARIOUS HBsAg CARRIER POPULATIONS1American Journal of Epidemiology, 1981
- Hepatitis B Virus Markers in 97 Long-Term Hemodialysis PatientsNephron, 1979
- Vaccine against hepatitis B — 18 months prevention in a high risk settingMedical Microbiology and Immunology, 1978
- Hemodialysis-Associated Hepatitis in the United States, 1974The Journal of Infectious Diseases, 1977
- Hepatitis B InfectionPublished by American Medical Association (AMA) ,1974
- SEROLOGICAL AND EPIDEMIOLOGICAL STUDIES OF HEPATITIS B IN HÆMODIALYSIS UNITSThe Lancet, 1973